Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiological evidence against a role for C-reactive protein causing leptin resistance.
Rutter MK, Sattar N, Tajar A, O'Neill TW, Lee DM, Bartfai G, Boonen S, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Lowe G, O'Rahilly S, Morris RW, Wu FC, Wannamethee SG; BRHS and EMAS Study Groups. Rutter MK, et al. Among authors: boonen s. Eur J Endocrinol. 2012 Dec 10;168(1):101-6. doi: 10.1530/EJE-12-0348. Print 2013 Jan. Eur J Endocrinol. 2012. PMID: 23047304
Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS).
Vanderschueren D, Pye SR, O'Neill TW, Lee DM, Jans I, Billen J, Gielen E, Laurent M, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Wu FC, Boonen S; EMAS Study Group. Vanderschueren D, et al. Among authors: boonen s. J Clin Endocrinol Metab. 2013 Mar;98(3):995-1005. doi: 10.1210/jc.2012-2772. Epub 2013 Feb 5. J Clin Endocrinol Metab. 2013. PMID: 23386642 Free article.
Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS).
Boonen S, Pye SR, O'Neill TW, Szulc P, Gielen E, Borghs H, Verschueren S, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Tajar A, Wu FC, Vanderschueren D; EMAS Group. Boonen S, et al. Eur J Endocrinol. 2011 Dec;165(6):977-86. doi: 10.1530/EJE-11-0353. Epub 2011 Sep 8. Eur J Endocrinol. 2011. PMID: 21903895 Clinical Trial.
Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men.
Ohlsson C, Nilsson ME, Tivesten A, Ryberg H, Mellström D, Karlsson MK, Ljunggren Ö, Labrie F, Orwoll ES, Lee DM, Pye SR, O'Neill TW, Finn JD, Adams JE, Ward KA, Boonen S, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC; EMAS Study Group; Vandenput L. Ohlsson C, et al. Among authors: boonen s. J Clin Endocrinol Metab. 2013 Jun;98(6):E1097-102. doi: 10.1210/jc.2012-3861. Epub 2013 Apr 30. J Clin Endocrinol Metab. 2013. PMID: 23633197 Free PMC article.
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial. Eastell R, et al. Among authors: boonen s. Osteoporos Int. 2010 Jul;21(7):1277-85. doi: 10.1007/s00198-009-1077-9. Epub 2009 Oct 3. Osteoporos Int. 2010. PMID: 19802508 Free PMC article. Clinical Trial.
Validation of the IOF quality of life questionnaire for patients with wrist fracture.
Lips P, Jameson K, Bianchi ML, Goemaere S, Boonen S, Reeve J, Stepan J, Johnell O, van Schoor NM, Dennison E, Kanis JA, Cooper C; Working Group for Quality of Life of the International Osteoporosis Foundation. Lips P, et al. Among authors: boonen s. Osteoporos Int. 2010 Jan;21(1):61-70. doi: 10.1007/s00198-009-0946-6. Epub 2009 Jun 6. Osteoporos Int. 2010. PMID: 19504036 Free PMC article.
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.
Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA; HORIZON Pivotal Fracture Trial. Eastell R, et al. Among authors: boonen s. J Clin Endocrinol Metab. 2009 Sep;94(9):3215-25. doi: 10.1210/jc.2008-2765. Epub 2009 Jun 30. J Clin Endocrinol Metab. 2009. PMID: 19567517 Free PMC article.
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.
Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group. Blumsohn A, et al. Among authors: boonen s. Osteoporos Int. 2011 Jun;22(6):1935-46. doi: 10.1007/s00198-010-1379-y. Epub 2010 Oct 12. Osteoporos Int. 2011. PMID: 20938767 Free PMC article. Clinical Trial.
480 results